(Adds Outlook)
Looking ahead, for the full year, Orthofix Medical Inc. (OFIX) raised its lower end of sales guidance to $790 million to $795 million from the earlier outlook of $785 million to $795 million. Analysts, on average, expect the firm to register revenue of $790.82 million, for the year.
Q1 Results:
Orthofix Medical revealed Loss for first quarter that decreased from the same period last year but missed the Street estimates.
The company's earnings totaled -$36.020 million, or -$0.95 per share. This compares with -$60.938 million, or -$1.71 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$0.33 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 7.7% to $188.608 million from $175.204 million last year.
Orthofix Medical Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$36.020 Mln. vs. -$60.938 Mln. last year.
-EPS (Q1): -$0.95 vs. -$1.71 last year.
-Revenue (Q1): $188.608 Mln vs. $175.204 Mln last year.
For comments and feedback: editorial@rttnews.com